StockData
Encompass Health Corp logo

Encompass Health Corp (EHC) stock

EHCNYSEServices-HospitalsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 16/3010% above fair value
$134.93−2.95 (-2.14%)

Close on Nov 18, 2026Market cap $13.31BP/E 22.0Yield 0.53%

Encompass Health free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Encompass Health's free cash flow for the twelve months ending Jun 30, 2026 was $413.40M, down 5.9% year over year. For fiscal 2025 it was $439.20M, up 21.9% from the year before. Over ten years it grew 1.6% a year on average. The highest annual figure on record is $507.90M in fiscal 2018.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$439.20M+21.9%
FY2024Dec 31, 2024$360.30M+34.6%
FY2023Dec 31, 2023$267.70M+120.0%
FY2022Dec 31, 2022$121.70M-28.5%
FY2021Dec 31, 2021$170.10M-45.5%
FY2020Dec 31, 2020$311.90M+18.6%
FY2019Dec 31, 2019$262.90M-48.2%
FY2018Dec 31, 2018$507.90M+17.4%
FY2017Dec 31, 2017$432.50M-6.5%
FY2016Dec 31, 2016$462.50M+23.8%
FY2015Dec 31, 2015$373.60M+36.4%
FY2014Dec 31, 2014$274.00M-0.4%
FY2013Dec 31, 2013$275.10M+1.6%
FY2012Dec 31, 2012$270.70M+11.7%
FY2011Dec 31, 2011$242.40M-9.6%
FY2010Dec 31, 2010$268.20M-21.8%
FY2009Dec 31, 2009$342.80M+99.9%
FY2008Dec 31, 2008$171.50M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$62.30M-45.0%
Q1 FY2026Mar 31, 2026$150.70M+20.1%
Q4 FY2025Dec 31, 2025$116.70M+45.7%
Q3 FY2025Sep 30, 2025$83.70M-30.4%
Q2 FY2025Jun 30, 2025$113.30M+87.3%
Q1 FY2025Mar 31, 2025$125.50M+26.3%
Q4 FY2024Dec 31, 2024$80.10M–
Q3 FY2024Sep 30, 2024$120.30M+83.7%
Q2 FY2024Jun 30, 2024$60.50M-28.7%
Q1 FY2024Mar 31, 2024$99.40M-22.4%
Q4 FY2023Dec 31, 2023-$10.70M–
Q3 FY2023Sep 30, 2023$65.50M–
Q2 FY2023Jun 30, 2023$84.80M-35.7%
Q1 FY2023Mar 31, 2023$128.10M+20.8%
Q4 FY2022Dec 31, 2022-$37.00M–
Q3 FY2022Sep 30, 2022-$79.20M-236.6%
Q2 FY2022Jun 30, 2022$131.90M-7.1%
Q1 FY2022Mar 31, 2022$106.00M+77.6%
Q4 FY2021Dec 31, 2021-$89.60M-162.6%
Q3 FY2021Sep 30, 2021$58.00M-30.8%
Q2 FY2021Jun 30, 2021$142.00M+2.0%
Q1 FY2021Mar 31, 2021$59.70M–
Q4 FY2020Dec 31, 2020$143.10M+38.8%
Q3 FY2020Sep 30, 2020$83.80M+713.6%
Q2 FY2020Jun 30, 2020$139.20M+124.9%
Q1 FY2020Mar 31, 2020-$54.20M-161.9%
Q4 FY2019Dec 31, 2019$103.10M+8.1%
Q3 FY2019Sep 30, 2019$10.30M-92.4%
Q2 FY2019Jun 30, 2019$61.90M-48.5%
Q1 FY2019Mar 31, 2019$87.60M-44.0%
Q4 FY2018Dec 31, 2018$95.40M+17.3%
Q3 FY2018Sep 30, 2018$135.80M+14.0%
Q2 FY2018Jun 30, 2018$120.30M+30.1%
Q1 FY2018Mar 31, 2018$156.40M+12.0%
Q4 FY2017Dec 31, 2017$81.30M+5.6%
Q3 FY2017Sep 30, 2017$119.10M-11.8%
Q2 FY2017Jun 30, 2017$92.50M–
Q1 FY2017Mar 31, 2017$139.60M–
Q4 FY2016Dec 31, 2016$77.00M–
Q3 FY2016Sep 30, 2016$135.10M–

More Encompass Health figures

See a number that looks wrong?